The Latest in IT Security

Twitter spam / medsdose.com

27
Apr
2012

This fake Twitter spam leads to a fake pharmacy at medsdose.com but it could easily be adapted for malware.

Date:      Thu, 26 Apr 2012 19:43:05 +0000
From:      Twitter [[email protected]]
To:      [email protected]
Subject:      Unusual activity with your account!

Hi, [email protected]

Our system detected unusual activity associated with your account.

Your account may be temporarily suspended for violations of the Twitter Rules.

We suspend accounts for investigation if we suspect an account has been hacked or compromised.

You need to confirm your email address to regain access to your account.

Once you regain access, you will be able to request a new password for your Twitter account.

You can find information on following automations and permitted following behaviors on the help page:

https://support.twitter.com/

The Twitter Team

Please do not reply to this message; it was sent from an unmonitored email address. This message is a service email related to your use of Twitter. For general inquiries or to request support with your Twitter account, please visit us at Twitter Support.

medsdose.com is hosted on 95.168.193.182 in the Czech Republic, this IP is used for several fake pharma sites and can be safely blocked.

  1. Brian May 11, 2012

    I got a fake email with the same link claiming I had missed friend requests on Facebook. Luckily I didn’t click on it and have now blocked it but it was very realistic and looked every bit as though it came from Facebook.

Leave a reply


Categories

SATURDAY, APRIL 20, 2024
WHITE PAPERS

Mission-Critical Broadband – Why Governments Should Partner with Commercial Operators:
Many governments embrace mobile network operator (MNO) networks as ...

ARA at Scale: How to Choose a Solution That Grows With Your Needs:
Application release automation (ARA) tools enable best practices in...

The Multi-Model Database:
Part of the “new normal” where data and cloud applications are ...

Featured

Archives

Latest Comments